GL1X · GenesisL1 explorer

Research workbench

Structure of HLA-A2 in complex with an altered peptide ligands based on mart-1 variant epitope

Analyse Structure of HLA-A2 in complex with an altered peptide ligands based on mart-1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WJ5
Type
protein
Length
770 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HLA class I histocompatibility antigen, a-2 alpha chain; Beta-2-microglobulin; Melanoma…
UniProt
P01892, P61769, Q16655
Pockets
8 · best druggability 0.69

Structure

x-ray diffraction · 3 distinct chains · 20% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, DHLA class I histocompatibility antigen, a-2 alpha chainprotein27528% helix, 40% strandP01892
B, EBeta-2-microglobulinprotein1000% helix, 49% strandP61769
C, FMelanoma antigen recognized by T-cells 1protein100% helix, 0% strandQ16655

Ligands and binding sites

  • GOL · Glycerol · additive · 13 copies · chains A, B, D, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16130.690.7854GOL
26070.680.7762GOL
36190.650.7674empty
44600.630.7754empty
5640.380.7919empty

Interfaces

7 interfaces between chains.

  • A–B · 1437 Ų buried · 29 hydrogen bonds · protein-protein
  • D–E · 1389 Ų buried · 28 hydrogen bonds · protein-protein
  • D–F · 921 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 914 Ų buried · 14 hydrogen bonds · protein-protein
  • A–E · 150 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 6 modified (disulfide, nonstandard).

Compared structures

  • 4WJ5 · Structure of HLA-A2 in complex with an altered peptide ligands based on Mart-1 variant… · the same entry in another collection · chain C against C, TM-score 1.00
  • P61769 · AlphaFold monomer V2.0 prediction for beta-2-microglobulin (P61769) · a predicted model of the same protein · chain B against A, TM-score 0.98
  • Q16655 · AlphaFold monomer V2.0 prediction for melanoma antigen recognized by T-cells 1 (Q16655) · a predicted model of the same protein · chain C against A, TM-score 0.32

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.